Current Research into Cures for Type-1 Diabetes

More News on Rituximab Background on the drug: Rituximab targets the CD20 part of the immune system's B cells (different from the pan...

For over 10 years, Dr. Faustman has been researching the theory that BCG (Bacillus Calmette-Guérin, used as vaccine for tuberculosis) could ...

The American Diabetes Association meeting (ADA 2011) just finished, and as with every year there has been a lot of news.  Normally, I only c...

At the bottom of my posts is the phrase "nothing here is official JDRF or JDCA news, views, policies or opinions".  Everyone knows...

LCT Starts A Phase-II Trial in Argentina LCT is developing an encapsulated pig islet cell product.  The hope is by implanting these cells,...

Diamyd Fails in Phase-III Trial Diamyd's European phase-III trial has failed. The official quote is "did not meet the primary eff...

I'm a little embarrassed that it has taken me so long to blog about Dr. Orban's results.  They were announced almost a year ago. ...